Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RSV-B controlled human infection model dose-escalation study in healthy adults
NL-OMON57515Completed
- Sponsor
- Centre for Human Drug Research
- Start
- May 2025
- Countries
- 1
01
Overview
Open-label, single-arm trial of RSV-B-I54 in respiratory syncytial virus disease (RSV), sponsored by Centre for Human Drug Research. Primary endpoints: Establishment of an RSV-B controlled human infection model, Safety and tolerability of RSV-B inoculation and 1 more. Started May 2025; status: completed.
02
Drugs
RSV-B-I54
03
Conditions
respiratory syncytial virus disease (RSV)
Beyond the preview
Go deeper on NL-OMON57515.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON57515.